Stephen Ward
Corporate Officer/Principal presso Cell Therapy Catapult Ltd.
Provenienza dei contatti di primo grado di Stephen Ward
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Cell Therapy Catapult Ltd.
Cell Therapy Catapult Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Ltd. engages in the development, delivery, and commercializing of cell and gene therapy. The company was founded in 2012 and is headquartered in London, the United Kingdom.
15
| Non-Profit Organization | Biotechnology | 15 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Stephen Ward tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Acambis Plc
Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
DRI Capital, Inc.
DRI Capital, Inc. Investment ManagersFinance DRI Capital, Inc. (DRI Capital) is a private equity firm, a subsidiary of Persis Holdings Ltd founded in 1992. The firm is headquartered in Toronto, Canada. | Investment Managers | Consultant / Advisor | |
CONSORT MEDICAL PLC | Pharmaceuticals: Major | Director/Board Member | |
VECTURA GROUP | Pharmaceuticals: Major | Director/Board Member Chairman | |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Touch Bionics Ltd.
Touch Bionics Ltd. Medical SpecialtiesHealth Technology Touch Bionics Ltd. provides prosthetic technologies and supporting services for the people with upper limb deficiencies. Its products develop upper-limb prosthetic technologies and specializes in myoelectronic hand and partial hand solutions, as well as a realistic silicone prostheses that are designed to closely match the skin of the wearer. Touch Bionics was founded in 2003 by David Gow and is headquartered in Livingston, the United Kingdom. | Medical Specialties | Director/Board Member | |
Innovate UK
Innovate UK Miscellaneous Commercial ServicesCommercial Services Innovate UK promotes, supports and invests in technology research, development, and commercialization. The firm provides access to information about the funding and support opportunities through a range of channels. The company was founded on July 1, 2007 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Calcivis Ltd.
Calcivis Ltd. Medical DistributorsDistribution Services Calcivis Ltd. provides dental assessment services. The firm offers preventive dentistry, CALCIVIS photoprotein, and CALCIVIS imaging devices. The company was founded by Adam Christie and Bruce Vernon in 2012 and is headquartered in Edinburgh, the United Kingdom. | Medical Distributors | Chairman | |
HCL TECHNOLOGIES LIMITED | Information Technology Services | Director/Board Member | |
BTG | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chairman | |
VITROLIFE AB | Medical Specialties | Chief Tech/Sci/R&D Officer | |
PA Consulting Group Ltd.
PA Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services PA Consulting Group Ltd. engages in the provision of management, systems, technology consulting, and innovation services. The company was founded by Ernest Button on September 3, 2015 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO | |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
ELECTRICAL GEODESICS INC | Medical Specialties | Director of Finance/CFO Director/Board Member | |
University College London | College/University | Graduate Degree Corporate Officer/Principal | |
Karus Therapeutics Ltd.
Karus Therapeutics Ltd. BiotechnologyHealth Technology Karus Therapeutics Ltd. provides therapies for treatment of cancer and inflammatory diseases. It offers HDAC6 and PI3K inhibitors for the treatment of cancer. The firm’s products in pipeline include KA-2237, KAR4000 Series and KAR3000 Series for the treatment of chronic inflammation, haematological malignancies, and solid tumours. The company was founded in July 2005 by Arasu Ganesan, Graham Keith Packham and Paul Townsend and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman | |
Acacia Pharma Ltd.
Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Acacia Pharma Ltd. develops supportive care product opportunities for post-surgical and cancer patients. It specializes in the discovery and development of cancer supportive care product opportunities based on established drugs. The firm’s product pipeline addresses supportive care indications, such as post-operative and chemotherapy-induced nausea and vomiting, xerostomia and cachexia. The company was founded by Andrew Muncey, Julian Clive Gilbert and Robert William Gristwood in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
The Bioindustry Association
The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | President | |
PHASE HOLOGRAPHIC IMAGING PHI AB | Biotechnology | Director/Board Member | |
NOVACYT | Medical Specialties | Director/Board Member | |
University of Aberystwyth | College/University | Undergraduate Degree | |
BioCity Group Ltd
BioCity Group Ltd Investment ManagersFinance BioCity Group Ltd (BioCity) is a venture capital firm founded in 2002. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
Royal Society of Edinburgh
Royal Society of Edinburgh Investment Trusts/Mutual FundsMiscellaneous The Royal Society of Edinburgh provides investment advice. The non-profit company is based in Edinburgh, UK and has subsidiaries in the United Kingdom. | Investment Trusts/Mutual Funds | Director/Board Member | |
Parkinson's Disease Society of the United Kingdom
Parkinson's Disease Society of the United Kingdom Miscellaneous Commercial ServicesCommercial Services The Parkinson's Disease Society of the United Kingdom is a non-profit organization that aims to support research on Parkinson's disease. The non-profit company is based in London, UK. The British company provides health information about Parkinson's for patients, caregivers, and family members. The organization also supports researchers to involve patients and the public in their work. The company offers a Parkinson's Learning Pathway for occupational therapists, physiotherapists, and speech and language therapists. The company was founded in 1969 by Mali Jenkins. Caroline Rassell has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
Cellzome, Inc.
Cellzome, Inc. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Cellzome, Inc. develops immune-inflammation therapy. The company is based in Philadelphia, PA. The company was founded by Spyridon Artavanis-Tsakonas, Stelios Papadopoulos. | Pharmaceuticals: Major | Chief Executive Officer | |
Cell Therapy Catapult Services Ltd.
Cell Therapy Catapult Services Ltd. BiotechnologyHealth Technology Cell Therapy Catapult Services Ltd. offers gene therapy services. The private company is based in London, UK. | Biotechnology | Chairman Director/Board Member | |
Atopix Therapeutics Ltd.
Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Queen Mary University of London | College/University | Graduate Degree | |
BBI Diagnostics Group 2 Plc
BBI Diagnostics Group 2 Plc Medical/Nursing ServicesHealth Services BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom. | Medical/Nursing Services | Chairman Director/Board Member | |
Lizard Bioconsulting Ltd.
Lizard Bioconsulting Ltd. Miscellaneous Commercial ServicesCommercial Services Lizard Bioconsulting Ltd. provides management consultancy services. The private company is based in Cambridge, UK. The British company was founded in 2013 by Nick Higgins. | Miscellaneous Commercial Services | Founder | |
YOURGENE HEALTH | Medical Specialties | Chairman | |
QUANTUM PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
SCHRODERS CAPITAL GLOBAL INNOVATION TRUST PLC - INOV | Investment Trusts/Mutual Funds | Chairman | |
ACACIA PHARMA GROUP PLC | Pharmaceuticals: Other | Director of Finance/CFO Director/Board Member | |
Magdalen College School
Magdalen College School Other Consumer ServicesConsumer Services Magdalen College School is an educational institution located in Brackley, UK. The school offers admission to students from year 6 to year 11 and sixth form. The school provides flu and COVID vaccinations to students in years 7-11. The school regularly organizes events such as open evenings, summer showcases, and athletics competitions. The school also offers teacher training programs through the Grand Union Training Partnership. The school communicates with parents through notices and social media. Magdalen College School was founded by Isaac Wodhams. | Other Consumer Services | Corporate Officer/Principal | |
Synpromics Ltd.
Synpromics Ltd. Chemicals: SpecialtyProcess Industries Synpromics Ltd. develops and commercializes synthetic promoters to control gene expressions and regulations. The firm is active in cell and gene therapy, biologics bioprocessing, and industrial biotechnology. The company was founded by Michael L. Robert in 2010 and is headquartered in Edinburgh, the United Kingdom. | Chemicals: Specialty | Chairman | |
Avvinity Therapeutics Ltd.
Avvinity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Avvinity Therapeutics Ltd. develops novel immuno-therapeutics. The British company was founded in 2016 by Mike Westby, Jonathan David Moore. The CEO is Nick Staples. | Pharmaceuticals: Major | Chairman | |
Ervaxx Ltd.
Ervaxx Ltd. Pharmaceuticals: MajorHealth Technology Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer. | Pharmaceuticals: Major | Director/Board Member | |
Institute For Research In Schools | Chairman | ||
Rinri Therapeutics Ltd.
Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Rinri Therapeutics Ltd. operates as a biotechnology company developing a novel cell-based therapy to restore hearing. The company was founded in 2018 and is headquartered in Sheffield, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Astronautx Ltd.
Astronautx Ltd. Miscellaneous Commercial ServicesCommercial Services Astronautx Ltd. engages in biotechnology company. The company was founded on April 1, 2019 and is headquartered in Reading, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Endlyz Therapeutics, Inc.
Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | Biotechnology | Chairman | |
LUMIRADX LIMITED | Medical Specialties | Director/Board Member | |
Laverock Therapeutics Ltd.
Laverock Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Laverock Therapeutics Ltd. develops regenerative medicines for hypo immune pancreatic islet cells and oncology therapeutics. The CEO of the British company is David C. Venables. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Vectura GmbH
Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Medical Specialties | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
Regno Unito | 39 |
Svezia | 5 |
Stati Uniti | 5 |
Canada | 2 |
India | 2 |
Settori
Health Technology | 28 |
Commercial Services | 10 |
Consumer Services | 5 |
Finance | 4 |
Miscellaneous | 3 |
Posizioni
Director/Board Member | 87 |
Chairman | 34 |
Independent Dir/Board Member | 24 |
Corporate Officer/Principal | 15 |
Director of Finance/CFO | 10 |
Contatti più connessi
Insiders | |
---|---|
John Brown | 36 |
Susan Foden | 34 |
Bruce Keogh | 19 |
Christine Soden | 18 |
Tim Edwards | 16 |
Nick Higgins | 13 |
Steven N. Chatfield | 11 |
Johan Hyllner | 6 |
Matthew Durdy | 3 |
Keith John Thompson | 1 |
Marc Leighton Turner | 1 |
Michael John Whitaker | 1 |
Jacqueline Anne Barry | 1 |
Uta Griesenbach | 1 |
Hilary Newiss | 1 |
- Borsa valori
- Insiders
- Stephen Ward
- Connessioni Società